Dr. Kong also previously served on the Board of Melinta Therapeutics, a pharmaceutical company formerly known as Cempra Pharmaceuticals, from September 2006 until June 2019. Dr. Williams served Duke University between 2001 and 2010 as Dean of the School of Medicine, Senior Vice Chancellor, Senior Advisor for International Strategy, and founding Dean of the Duke-NUS Graduate Medical School Singapore. Kong previously served on the board of directors of Alimera Sciences, Inc., a pharmaceutical company that specializes in the commercialization and development of ophthalmic . Labcorp Appoints Dr. Paul Rothman to Board of Directors - Yahoo Finance She co-founded and is a board member for No More Kids with Cancer, which is dedicated to accelerating the discovery of safer, less toxic and more effective treatments for children with cancer, and she serves on the Corporate Council and Brain Tumor Research Board of Visitors for The Childrens Hospital of Philadelphia. Mr. Blingard has served on the board of Laboratoire Pierre Fabre S.A. (France) since 2013, which is owned by The Pierre Fabre Foundation, a government-recognized public organization. ET that day to discuss the results. Pike served as CEO and board member of Quintiles Transnational Holdings, Inc. (Quintiles), a leading fully integrated biopharmaceutical services company offering clinical, commercial and consulting solutions worldwide. Prior to joining eBay, Ms. Parham served as head of Global Marketing Innovation and Initiatives and head of Global Marketing Services at Visa, Inc. from 2008 to 2010. Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. Executive Vice President and Chief Financial Officer. Ms. Parham founded and serves as Executive Chairman of the Board of Directors for Shyn, an oral care product company since January 2018. She was previously a director of the board of Chiquita Brands International from 2009 to 2012, and was chairwoman of the board from 2012 until the companys acquisition in 2015. From January 2, 2015 to January 30, 2020, Dr. Gilliland previously served as President and Director of the Fred Hutchinson Cancer Research Center. Richelle Parham has served as a director of the Company since February 8, 2016. BURLINGTON, N.C. , June 7, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a leading global life sciences company, today announced the appointment of Dr. Paul Rothman to its Board of Directors as an independent member. Senior Finance/Operations Analyst. Ms. Anderson has served as a director of Abercrombie & Fitch Co. since February 2018, The Sherwin-Williams Company since April 2019, and Worthington Industries, Inc. since September 2010. Before joining Sofinnova, Dr. Kong was a general partner from 2000 to 2010 at Intersouth Partners, a venture capital firm where he was a founding investor or board member for various life science ventures, several of which were acquired by large pharmaceutical companies. Dr. Rothman holds a Bachelor in Science in biology from the Massachusetts Institute of Technology and an M.D. Novant Health Inc. said Monday it has appointed former Labcorp top executive David King to its board of trustees. Ms. Anderson also has significant expertise in the areas of accounting and financial reporting, corporate finance, corporate governance, and executive compensation through her service on other large public company boards. Dr. Williams is a member of the National Academy of Medicine, and a Fellow of the American Association for the Advancement of Science. Corporate Governance Highlights | Take-Two Interactive Software, Inc. Prior to her position as President, Ms. Kliphouse served as President of the North American division of Google Cloud from June 2019. Before joining Labcorp, Adam held a variety of senior leadership positions at Merck & Co., Inc. and Ph.D. in Biomedical Engineering and an M.B.A. from Duke University. D. Gary Gilliland has served as a director of the Company since April 1, 2014. Prior to Qurate Retail Group, Mr. Davis served as Chief Financial Officer of J. C. Penney Company Inc., a retail company, from July 2017 until September 2018. Mark has long been responsible for the companys global supply chain operations worldwide. Through our unparalleled diagnostics and drug development capabilities, we provide insights and accelerate innovations to improve health and improve lives. lab testsright here, right now. Media: Christopher Allman-Bradshaw 336-436-8263[emailprotected], Investors: Chas Cook 336-436-5076 [emailprotected]. He earned a B.S. GRAHAM Alamance Community College alumni, faculty, staff and students were honored by the college May 25 at the 2023 Celebrating Excellence Awards, hosted by the ACC Board of Trustees and the. Dr. Kong holds an M.D. Cautionary Statement Regarding Forward-Looking StatementsThis press release contains forward-looking statements, including but not limited to statements with respect to the Companys leadership, future operations and opportunities for future growth. This number represents the median, which is the midpoint of the ranges from our proprietary Total Pay Estimate model and based on salaries collected from our users. Mark Schroeder has served as Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer at Labcorp since 2023. First look at Labcorp spinoff: CEO Pike wants a 'magnet' workforce Since joining Johnson & Johnson in 1988, Ms. Wengel has served in various positions of increasing responsibility across the enterprise both in the United States and various locations globally, including as the Worldwide Vice President, Chief Supply Chain Officer from March 2014 until July 2018, and as the companys first Chief Quality Officer from April 2010 until March 2014. He was also an Investigator of the Howard Hughes Medical Institute from 1996 to 2009, Director of the Leukemia Program at the Dana-Farber/Harvard Cancer Center from 2002 to 2009, and Director of the Cancer Stem Cell Program of the Harvard Stem Cell Institute from 2004 to 2009. Mark has more than 15 years of experience with Labcorp, having joined in 2007. Jon holds a bachelors degree in mechanical engineering from Northeastern University. Before joining Labcorp, Mark was the Senior Vice President of Sales, Operations and Business Development at DSC Logistics. Her experience also includes 13 years at Digitas, Inc., a leading marketing agency, where she held a variety of senior leadership roles, including senior vice president and general manager of the agencys Chicago office. (Press Enter or Space to Go to Landing Page or Press Down to expand Menu), Labcorp appoints Johnson & Johnson executive Kathryn Wengel to the Board of Directors, Federally Qualified Health Centers (FQHCs), Combatting Modern Slavery and Human Trafficking Statement. Novant names former Labcorp executive to board of trustees Ms. Anderson has a strong record of leadership in operations, strategy, finance and talent management as a result of her experience at Wendys. Prior to that, he was named Lead Independent Director after serving as a director of the company since 2013. Labcorp (LH) Announces Completion of the Fortrea Spin-off Prior to Sapient, she held roles in sales management and product marketing at Dun & Bradstreet. Sandy obtained her B.S. From 2009 until he joined Penn Medicine in 2013, Dr. Gilliland was Senior Vice President of Merck Research Laboratories and Oncology Franchise Head. Lance also worked as Chief Information Officer and President of Kellstrom Defense Aerospace Inc., a fully integrated supply chain firm, from 2000 to 2007. Previously, he served on the boards of the European Federation of Pharmaceutical Industries and Associations (EFPIA), where he led the Policy and Access Committee, the Healthcare Leadership Council and the Merial Animal Health Company. Dr. Kong also previously served on the Board of Melinta Therapeutics, a pharmaceutical company formerly known as Cempra Pharmaceuticals, from September 2006 until June 2019. Prior to VF, Anita was Senior Vice President, Chief Human Resources and Administration Officer at ADT Corporation, where she led the human resources, environment, health and safety, and corporate communications functions. In February 2021, she closed a $103M venture capital financing with a new lead and a blue-chip syndicate, and in February 2022, she sold the company to Labcorp for $450M upfront and up to $575M in total. At Merck, Dr. Gilliland oversaw first-in-human studies, proof-of-concept trials, and Phase II/III registration trials that included the development of pembrolizumab (anti-PD1) for treatment of cancer, and managed all preclinical and clinical oncology-licensing activities. Brian serves on the Board of Directors of the North Carolina Healthcare Quality Alliance. Each of Labcorp's stockholders received one share of Fortrea common stock for every share of Labcorp common stock they held as of the record date. Executive Vice President and Chief Human Resources Officer. Garheng Kong has served as a director of the Company since December 1, 2013. Ms. Parham currently serves as President of Global eCommerce and Business Development for Universal Music Group, a music-based entertainment company, a position she has held since June 2021. Prior to that, Mr. Neupert served as Corporate Vice President of the Microsoft Health Solutions Group from its formation in 2005 to January 2012. Mr. Davis currently serves as the Chief Financial Officer of Dollar Tree, Inc., a leading operator of discount variety stores, a role he has held since October 2022. She is currently a Strategic Advisor at Camden Partners, a private equity firm, where she previously served as a General Partner from October 2016 to October 2019. LabCorp Announces Changes to Board of Directors | Labcorp Dr. Kong previously served on the board of directors of Alimera Sciences, Inc., a pharmaceutical company that specializes in the commercialization and development of ophthalmic pharmaceuticals, from October 2012 to May 2023 and of Histogenics Corporation, a public biotechnology company, from July 2012 until February 2019, each of which he joined in connection with an investment by Sofinnova, and Avedro, Inc., a commercial-stage ophthalmic medical technology company, from April 2017 until November 2019. These factors, in some cases, have affected and in the future (together with other factors) could affect the Companys ability to implement the Companys business strategy and actual results could differ materially from those suggested by these forward-looking statements. Dr. Rothman's appointment is . Laboratory Director Salaries in the United States for Labcorp - Indeed Prior to her current role, Sandy served as Senior Vice President, Global General Counsel, Chief Compliance Officer and Corporate Secretary. Mr. Neupert was an Operating Partner at Health Evolution Partners, a health only, middle market private equity firm, from January 2012 until June 2015. Labcorp Appoints Dr. Paul Rothman to Board of Directors 555 Twin Dolphin Dr Ste 370 Previously, she was the Executive Vice President, Chief Administrative Officer at Shire plc, a global biopharmaceutical company that is now part of Takeda Pharmaceuticals. He was previously a general partner at Sofinnova Capital, a position he held from 2010 to 2013. LabCorp Board of Directors News - LabCorp News from EIN News Peter M. Neupert has served as a director of the Company since January 1, 2013. from the University of Virginia School of Law. Prior to these appointments he was president of The J. David Gladstone Institutes since November 2009, and he served as Chief Executive Officer of The J. David Gladstone Foundation, a non-profit organization supporting The J. David Gladstone Institutes, until December 31, 2018. Jeffrey A. Davis has served as a director of the Company since December 1, 2019. Dr. Kong received undergraduate degrees in both Chemical Engineering and Biological Sciences from Stanford, and earned an M.D., Ph.D. and MBA from Duke University. Glenn Eisenberg has served as Executive Vice President and Chief Financial Officer of Labcorp since 2014. He previously led the West Division for Labcorp as well as its Integrated Genetics, Integrated Oncology and Dianon pathology businesses. Further information on potential factors, risks and uncertainties that could affect operating and financial results is included in the Companys most recent Annual Report on Form 10-K and subsequent Forms 10-Q, including in each case under the heading RISK FACTORS, and in the Companys other filings with the SEC. He was also an Investigator of the Howard Hughes Medical Institute from 1996 to 2009, Director of the Leukemia Program at the Dana-Farber/Harvard Cancer Center from 2002 to 2009, and Director of the Cancer Stem Cell Program of the Harvard Stem Cell Institute from 2004 to 2009. Ms. Wengel is also a member of the Executive Committee of the National Association of Manufacturers (NAM) in the US. Dr. Williams has served as a director of Tenaya Therapeutics, Inc. since October 2016 and has been a director of Amgen, Inc. since October 2014. Mr. Neupert serves as the Boards lead independent director. Why Shares of Labcorp Dropped Monday | Nasdaq Salary information comes from 78 data points collected directly from employees, users, and past and present job advertisements on Indeed in the past 36 months. Ms. Parham served as a Managing Director of WestRiver Group, which provides integrated capital solutions to the global innovation economy with investments focused on technology, life sciences, energy, and experiential sectors, from October 2019 to May 2021. Sandra (Sandy) van der Vaart's LinkedIn Profile. Ms. Anderson was Chief Executive Officer of Wendys International, Inc., a restaurant operating and franchising company, from April 2006 until September 2008, when the company was merged with Triarc. EVP and President, Early Development Research Laboratories and Chief Medical and Scientific Officer. She has also served as CEO of Yardarm Technologies, a firearm safety and tracking firm, and has advised numerous startups on product strategy. The company will host a conference call and webcast beginning at 9 a.m. All Rights Reserved. Brian led efforts to expand the accessibility of COVID-19 PCR testing, used his expertise to help bring understanding about testing and treatment options to the public, and drove advancements to the way the company works with the broader healthcare industry. Board of Directors - Corporate Governance | Solvay About Labcorp As CEO, Megan led PGDx through a business transformation and several noteworthy milestones, including securing the first-ever FDA clearance of a comprehensive genomic profiling product, Medicare reimbursement and several high-impact co-development and commercial partnerships. Labcorp Appoints Google Cloud Executive Kirsten Kliphouse to Its Board At Merck, Dr. Gilliland oversaw first-in-human studies, proof-of-concept trials, and Phase II/III registration trials that included the development of pembrolizumab (anti-PD1) for treatment of cancer, and managed all preclinical and clinical oncology-licensing activities. She also serves on the Executive Advisory Board for Gartners Supply Chain practice and is a member of Supply Chain 50. Kerrii B. Anderson has served as a director of the Company since May 17, 2006. Jon DiVincenzo has served as Executive Vice President and President, Central Laboratories and International at Labcorp since 2023. Jeffrey A. Davis has served as a director of the Company since December 1, 2019. He also served as special advisor to the CEO of Merck from January to July 2019. BURLINGTON, N.C.--(BUSINESS WIRE)--Mar. Mr. Blingard is also a member of the Bill and Melinda Gates Foundation CEO Roundtable and has served on the Novo Advisory Group of Novo Holdings, which is wholly owned by the Novo Nordisk Foundation, since 1998. Beauty, Inc. since March 16, 2018. LabCorp Announces Change to Board of Directors Dr. Williams serves currently as Senior Advisor for Science & Technology at Duke University and as President Emeritus of The J. David Gladstone Institutes, a non-profit biomedical research enterprise, holding both positions since January 1, 2018. has served as Executive Vice President and President, Early Development Research Laboratories and Chief Medical and Scientific Officer at Labcorp since 2023. BURLINGTON, N.C., Oct. 13, 2022 Labcorp (NYSE: LH), a leading global life sciences company, today announced that Kirsten Kliphouse, president of Americas, Google Cloud, has joined its Board of Directors as an independent member. Dr. Williams also currently is Professor of Medicine at the University of California San Francisco and Professor of Medicine at Duke University. Before joining Sofinnova, Dr. Kong was a general partner from 2000 to 2010 at Intersouth Partners, a venture capital firm where he was a founding investor or board member for various life science ventures, several of which were acquired by large pharmaceutical companies. Peter M. Neupert has served as a director of the Company since January 1, 2013. He had served in that position since 2002. He served on the Board of Directors of Quality Systems, Inc., now known as NextGen Healthcare, Inc., from August 2013 to January 2014. Prior to Qurate Retail Group, Mr. Davis served as Chief Financial Officer of J. C. Penney Company Inc., a retail company, from July 2017 until September 2018. Prior to his time at Dollar Tree, Inc., Mr. Davis served as Chief Financial Officer of Qurate Retail Group, a leading retailer and media conglomerate comprised of eight retail brands including QVC, HSN and Zulily, from October 2018 through August 2022. Ms. Kliphouse currently serves as the President of Google Cloud Americas, a position she has held since March 2022, where she is responsible for leading and growing the sales, go-to-market, customer engagement, channel, and services organizations. Dr. Kong has served on the board of directors of Alimera Sciences, Inc., a pharmaceutical company that specializes in the commercialization and development of ophthalmic pharmaceuticals, since October 2012, when Sofinnova made an investment in Alimera, where he also served as the Chairman of the Compensation Committee. He also previously served as President and Chief Operating Officer of United Dominion Industries Ltd., a global diversified industrial company that is now a subsidiary of SPX Corporation, after working in several executive roles at the company, including Executive Vice President, Chief Financial Officer, and President of its test instrumentation segment. Mr. Blingard continues to serve on the board of directors of bioMrieux and as Vice President of Institut Mrieux. Fortrea Holdings completes spin-off from Labcorp - TipRanks Vice-Chair. Ms. Anderson has served as a director and a member of the Compensation Committee and Audit Committee of Worthington Industries, Inc. since September 2010, a director and member of the Audit and Finance Committee of Abercrombie & Fitch Co. since February 2018, and a director and a member of the Compensation and Management Development Committee of The Sherwin-Williams Company since April 2019. HCIT . Labcorp is coming off a lackluster first-quarter report. Mr. Blingard retired as Chairman and Chief Executive Officer of Ipsen SA, a diversified French healthcare holding company, on November 22, 2010. There, she rapidly progressed through commercial leadership roles, most recently serving as Senior Director of Commercial Operations, leading commercial organizations across four divisions that spanned clinical chemistry, molecular diagnostics, tissue diagnostics and point of care portfolios, addressing multiple market segments. She is a graduate of the United States Military Academy at West Point and earned her Master of Public Health from the University of North Carolina at Chapel Hill. Board of Directors Leslie L. Campbell Leslie L. Campbell was appointed to our Board in April 2021. Dr. Williams has served as a director of Tenaya Therapeutics, Inc. since October 2016 and has been a director of Amgen, Inc. since October 2014. Labcorp Completes Spin-off of Fortrea | Labcorp Board of Directors Executive Team Adam Schechter Chairman, President and Chief Executive Officer Global business leader Adam Schechter became Chief Executive Officer of Labcorp in 2019 and Chairman of the Board in May 2020. Mr. Belingard is also a director at Transgene SA, an Institut Mrieux company. She holds a B.B.A. BURLINGTON, N.C., October 13, 2022 -- ( BUSINESS WIRE )--Labcorp (NYSE: LH), a leading global life sciences company, today announced that Kirsten Kliphouse, president of Americas, Google Cloud,. Dr. Kong is the managing partner of HealthQuest Capital, a healthcare-focused investment firm, a role he has held since he founded HealthQuest Capital in 2012. Mr. Neupert was an Operating Partner at Health Evolution Partners, a health only, middle market private equity firm, from January 2012 until June 2015. Executive Vice President and Chief Information and Technology Officer. Labcorp | Global Life Sciences Leader in Lab Diagnostics & Drug Development Leadership Team | Labcorp Pike has more than 30 years of industry experience. Kerrii B. Anderson has served as a director of the Company since May 17, 2006. 2023 Labcorp. His extensive experience at Merck also included global and U.S.-focused leadership roles spanning sales, marketing and managed markets, as well as business and product development. . Labcorp spin offs Fortrea, creating 19,000-employee life science firm Risa Lavizzo-Mourey, MD, MBA. EVP and Chief Strategy and Transformation Officer. Prior to that, she served as Labcorps Senior Vice President, Deputy Chief Legal Officer from September 2015 until February 2019 and Senior Vice President, General Counsel and Assistant Secretary from January 2009 to September 2015. Mr. Blingard retired as Chairman and Chief Executive Officer of Ipsen SA, a diversified French healthcare holding company, on November 22, 2010. He also served as senior director of laboratory services and North American medical director. Barbara W. Bodem is an independent director who joined our Board in January 2022 and is Chair of the Audit Committee. Lead Independent Director, Chair of the Nominating and Corporate Governance. Healthcare IT Council. Ms. Wengel also serves as the Chairman of the Board of Directors of GS1 Global, a cross-industry standards organization, serves on the Executive Committee as Vice-Chairman of the U.S. National Association of Manufacturers, and is a founding Advisory Board Member of AWESOME, or Advancing Womens Excellence in Supply Chain Operations Management and Education. Incyte Leadership | Incyte.com All Rights Reserved. Im honored to join Labcorps board, and I look forward to working with Adam and the entire Labcorp team to deliver on its important mission and the best interests of patients, clients, and shareholders.. Ms. Parham was responsible, globally, for eBay brand strategy and brand marketing, to reach 108+ million active eBay users, Internet marketing and for customer relationship management. Labcorp Appoints Dr. Paul Rothman to Board of Directors BURLINGTON, N.C., June 29, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a leading global life sciences company, will release its financial results for the second quarter of 2023 before the market opens on Thursday, July 27, 2023. Ying Liang. Prior to these appointments he was president of The J. David Gladstone Institutes since November 2009, and he served as Chief Executive Officer of The J. David Gladstone Foundation, a non-profit organization supporting The J. David Gladstone Institutes, until December 31, 2018. ET on Friday, June 30, 2023, Labcorp shareholders were distributed one share of Fortrea common stock for every share of Labcorp common . Solvay's board of directors promotes good governance practices that create transparent dialogue among the group's stakeholders. team HealthQuest Capital in health policy and administration from the University of North Carolina at Chapel Hill. Mr. Neupert brings to the Board experience as a recognized expert in health information technology and perspective on how to grow shareholder value leveraging business strategies with technology. All Rights Reserved. Labcorp OnDemand puts your health in your hands by letting you purchase lab tests online. Learn more about us at www.Labcorp.com or follow us on LinkedIn and Twitter @Labcorp. Prior to that, he was the global Chief Operating Officer for Accentures Resources operating group, and he also served as Accentures Chief Strategy Officer and a member of the executive leadership team for Accentures IPO in July 2001. Dr. Williams also currently is Professor of Medicine at the University of California San Francisco and Professor of Medicine at Duke University. As part of Labcorp, Fortrea last year recorded revenue of about $3.1 billion, with 54 percent of this amount coming from leading pharmaceutical companies. Teams. Amy also worked for Sapient from 1996 to 2011, where she held executive leadership roles, including Managing Director for its New York and West Coast offices, and Chief Marketing Officer. Labcorp Corporate Governance Guidelines 1. She has been with Labcorp since 2001 and has served in various other roles within the legal department. Fortrea completes spin off from Labcrop to form $3B public company with
New Homes For Rent Houston, Texas,
Attributeerror Stringarray' Object Has No Attribute 'tolist,
One Heart Club All Of Us Are Dead,
Wisconsin Cbrf Regulations,
Articles L
